1. Home
  2. NEXA vs PGEN Comparison

NEXA vs PGEN Comparison

Compare NEXA & PGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Nexa Resources S.A.

NEXA

Nexa Resources S.A.

HOLD

Current Price

$11.07

Market Cap

1.3B

ML Signal

HOLD

Logo Precigen Inc.

PGEN

Precigen Inc.

HOLD

Current Price

$3.94

Market Cap

1.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NEXA
PGEN
Founded
1956
1998
Country
Luxembourg
United States
Employees
N/A
N/A
Industry
Metal Mining
Biotechnology: Pharmaceutical Preparations
Sector
Basic Materials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.3B
1.4B
IPO Year
2017
2013

Fundamental Metrics

Financial Performance
Metric
NEXA
PGEN
Price
$11.07
$3.94
Analyst Decision
Hold
Buy
Analyst Count
5
5
Target Price
$10.10
$8.33
AVG Volume (30 Days)
473.4K
5.1M
Earning Date
04-28-2026
05-13-2026
Dividend Yield
1.19%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$230,981,000.00
Revenue This Year
$6.99
$938.10
Revenue Next Year
N/A
$108.60
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$4.62
$1.11
52 Week High
$14.94
$5.47

Technical Indicators

Market Signals
Indicator
NEXA
PGEN
Relative Strength Index (RSI) 52.59 55.44
Support Level $10.72 $3.92
Resistance Level $14.84 $4.44
Average True Range (ATR) 0.58 0.29
MACD 0.14 0.11
Stochastic Oscillator 89.11 72.87

Price Performance

Historical Comparison
NEXA
PGEN

About NEXA Nexa Resources S.A.

Nexa Resources SA is a low-cost integrated zinc producer. It produces copper, silver, and gold as byproducts. The company operates through two segments namely Mining and Smelting. Its Mining segment consists of various operating units includes mineral exploration activities and the production of zinc concentrates, copper concentrates and concentrates. The Smelting segment comprises operating units which include facilities recovering and refining zinc metal out of feed materials such as zinc concentrates or secondary feed materials. It generates maximum revenue from the Smelting segment. Geographically It has a presence in Brazil, Peru, the United States of America, Switzerland, Japan, Argentina, South Korea, Colombia, Vietnam, Malaysia and other countries.

About PGEN Precigen Inc.

Precigen Inc is a commercial-stage biopharmaceutical company focused on developing precision medicines to improve the lives of patients, targeting immuno-oncology, autoimmune disorders, and infectious diseases using its proprietary and complementary technology platforms. These platforms support the development of gene programs, delivery through viral, non-viral, and microbe-based approaches, and control of gene expression for safety and efficacy. Its key platforms include AdenoVerse immunotherapy and UltraCAR-T, supported by the UltraPorator device for rapid and cost-effective manufacturing. Its clinical pipeline includes PRGN-2009, PRGN-3005, PRGN-3006, and PRGN-3007. Its reportable segments are Biopharmaceuticals and Exemplar.

Share on Social Networks: